October 19, 2017 9:37 AM ET


Company Overview of KinoPharma, Inc.

Company Overview

KinoPharma, Inc. offers discovery and development of small molecule drugs for Ser/Thr kinases based on the proprietary platform technologies. KinoPharma, Inc. was founded in 2005 and is based in Tokyo, Japan.

5-25-16 Hongo




Founded in 2005


81 3 5299 9711


81 3 5299 9712

Key Executives for KinoPharma, Inc.

KinoPharma, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
ACTGen, Inc. Asia
Amano Enzyme Inc. Asia
Ambicion Inc. Asia
ArBlast Co., Ltd. Asia
Argenes, Inc. Asia

Recent Private Companies Transactions

Private Placement
December 28, 2016

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
Bertelsmann AG Europe

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact KinoPharma, Inc., please visit www.kinopharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.